vindira retweeted
We aim to push the pace of addressing unmet needs in #cancer. Our Immuno-Architects work towards this. #BMSatESMO
vindira retweeted
Meet Dave Feltquate, Liver & Brain Cancer Development Lead, who works to bring new approaches to patients. #ASCO15
amp.twimg.com/v/d6d5f956-5c5…
vindira retweeted
Nivolumab extends lung cancer survival wb.md/1HXlAdW #ASCO15
vindira retweeted
#ASCO15 $BMY Opdivo liver cancer data early but look very promising
ORR 19%; 12mo OS rate 62%
http://t.co/9ut4GdehRL via @JacobPlieth
vindira retweeted
On the Pathway to #ASCO15! Follow @BMSNews for updates from our road trip and the meeting #BMSatASCO xitter.cf/bmsnews/status/6039885…
vindira retweeted
New pos. survival data of phase 1 NSCLC patients on Nivolumab, the Investig. PD-1 Immune Checkpoint Inhibitors marketwatch.com/story/additi… #lcsm
vindira retweeted
Nivolumab continues to demonstrate clinical activity in previously treated patients with advanced NSCLC ow.ly/qhuVL #WCLC13
vindira retweeted
Concurrent RX w Ipi and Nivo: 50% had 80% or greater disease reduction. Est 1 yr OS > 80%. Ph3 trial open. #speechless #ASCO13
vindira retweeted
Sequenced regimen, pts can respond to PD1 after Ipi failure. Concurrent regimen had higher RR. Responses rapid and dramatic. #ASCO13
vindira retweeted
The business of cancer. Lucrative. There is no #ASCO13 without these mega-marketing booths.
vindira retweeted
Replying to @adamfeuerstein
vindira retweeted
Wow, It's Actually Happening! Arrested Development Reaches Deal to Produce New Episodes eonli.ne/sJ9APd
vindira retweeted
Amanda Knox Is Innocent ... freed and to be released from prison abcn.ws/ni1x3X #AmandaKnox
vindira retweeted
#amandaknox is.....guilty of slander...acquitted of murder...to b released
vindira retweeted
BREAKING NEWS - TRUCKS LOCATED. Not part of any threat. Authorities still assessing. Question is if plot in play or aspirational (a plan)
vindira retweeted
US Intel deem threat info abt at least 3 entering us to launch truck bomb around 9/11 - "CREDIBLE BUT UNCONFIRMED"


















